Diplomat Pharmacy expands relationship with SMRxT to improve patient care

Diplomat Pharmacy, Inc, is expanding its strategic relationship with medication adherence company SMRxT, creator of the Nomi system. Nomi, is a medication adherence system that uses real-time data and communications to improve patient outcomes. Nomi accurately captures multiple data points from patients, in real-time, to monitor how and when they take their medication. The system then translates patient behaviour into actionable information for patient interventions and engagement.

Nomi sensor technologies record when a patient takes their medication, including the number of tablets. Real-time reporting gives healthcare providers the insight to manage patient adherence challenges.

Diplomat is now integrating data from Nomi into its end-to-end pharmacy operating system. This will enable a more fully integrated approach to medication adherence and patient engagement.

"We saw an opportunity to expand our patient care model by adding technology," said Gary Rice, Diplomat's executive vice president of operations. "Our continuing integration of systems and technology helps us as we work to fill gaps in care for patients. Taking care of patients has always been the centre of our mission."

With the Nomi system, pharmacies know a patient's precise dosing behaviour and can contact them right away to resolve adherence barriers, such as side effects that deter them from continuing therapy.

"We're excited to expand our business relationship with Diplomat," said Michael Huffer, RPh, president and CEO of SMRxT. "This new data integration should help Diplomat provide the right care for each patient in even more tailored and efficient ways."



Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’

WhatsApp Group for Pharma Literati